Podcast

Expert Conversations: SLGT2 Inhibitors for HF, Cardio-Renal Connection

06/14/2018

 

In this podcast, Dr Seth Baum interviews Dr Mikhail Kosiborod about clinical trial data surrounding the possible mechanisms of action of SLGT2 inhibitors for heart failure, as well as the cardio-renal connection.

Seth Baum, MD, is president of the American Society for Preventive Cardiology (ASPC), clinical affiliate professor at the Schmidt College of Medicine at Florida Atlantic University, and CEO of Excel Medical Clinical Trials in Boca Raton, Florida.

Mikhail N. Kosiborod, MD, is a cardiologist at Saint Luke's Cardiovascular Consultants in Lees Summit, Missouri; professor of medicine at the University of Missouri; and researcher in HFrEF and HFpEF.

 

For more content related to heart failure, visit Heart Failure Care360.

 

Published in partnership with American Society for Preventive Cardiology

Related Content

Primary Care
Primary Care
James Matera, MD, on the ACC/AHA Hypertension Guideline
01/21/2019
In this 3-minute mini-podcast, Dr James Matera from CentraState Medical Center discusses how the 2017 ACC/AHA hypertension guideline has changed the landscape when it comes to managing comorbid...
01/21/2019
Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
Mardi Gomberg-Maitland, MD, MSc, on Right Heart Catheterization in the Management of Patients With PH
05/18/2015
In this podcast, Mardi Gomberg-Maitland, MD, MSc, speaks about the reasons she believes right heart catheterization is necessary in the follow-up management of patients with pulmonary hypertension,...
05/18/2015
Inflammatory Bowel Disease
Inflammatory Bowel Disease
Benjamin L. Cohen, MD, on IBD and UC: Implementing an Interdisciplinary Approach
10/04/2018
Dr Ben Cohen from Mount Sinai discusses inflammatory bowel disease and vaccination, as well as caring for patients with ulcerative colitis and when surgery is indicated in patients with UC.
10/04/2018
Cardiometabolic Risk
Cardiometabolic Risk
COMMENTARY: Metabolic Syndrome Is the New "Silent Killer"
05/18/2017
Charles Hennekens, MD, from Florida Atlantic University, discusses his recent commentary on metabolic syndrome as the new silent killer.
05/18/2017
Esophageal Disorders
Esophageal Disorders
Sangeeta Agrawal, MD, on MicroRNA and the Progression of Barrett Esophagus
09/25/2018
Dr Sangeeta Agrawal, the Division Director of Gastroenterology at Wright State University discusses her recently published systematic review on MicroRNA and the progression of Barrett esophagus.
09/25/2018